"Aleks 1977" Ltd is an innovative company founded in 2011, with a major research and development (RD) activity, for which was awarded with a "Pythagoras 2016" award as the company with highest investment in RD in 2017. The team of the company has great scientific experience in creating innovative products for the market. The main objective of the project proposal is the development of PRODUCT innovation, a novelty of WORLD significance, which will reach TRL6 technological readiness. The PRODUCT INNOVATION is a laboratory sample of Gel for Varicose and Diabetic Wound (LSGVDW) designed for the needs of many people and is in line with Objective 1 of ”Bio-Technology with Direct Application to a Healthy Lifestyle" The acquisition of DMA and DNA, the formation of a highly qualified team and external services are needed to develop innovations in biotechnology, to isolate and study active ingredients from Helix aspersa snails, Plantago major, Calendula officinalis, hydrolysates from collagen, DNA and RNA, and copper ions, to create the innovative LSGVDW Another important objective is the development of environmentally friendly technologies for obtaining extracts and combining them in LSGVDW to achieve a wide range of biological activity An innovative method for the application of LSGVDW to the wounds will be developed by combining it with laser therapy. These will stimulate the penetration of active substances, regeneration of cells and breakdown of necrotic tissue, which will have a healing and preventative effect in suppressing inflammatory processes on the vein walls as well as protecting capillaries and blood vessels. The expected outcomes from the completion of the project are: Providing laboratory technology and a laboratory gel sample for the treatment of varicose and diabetic wounds, which are a pandemic of our time that may lead to limb amputation if untreated Increasing the competitiveness of the company on the Bulgarian and international market
Overview
Status | Closed (completion date) |
---|---|
Start date | 20 Jul, 2018 |
End date | 13 Nov, 2020 |
Contract date | 20 Jul, 2018 |
Programme
Beneficiary
Financial information
Total cost | 321,380.00 |
---|---|
Grant | 224,966.00 |
Self finance | 96,414.00 |
Total paid | 218,650.83 |
EU participation percent | 85.0% |
Location